The global Nucleic Acid Amplification Detection and Diagnostics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Nucleic acid amplification technologies are used for the rapid and accurate diagnosis of chronic and infectious diseases. The nucleic acid amplification is one of the important tool for wide aspects of life science technologies including, clinical medicine development, diagnosis of infectious diseases, and gene cloning.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The publisher report includes an overview of the development of the Nucleic Acid Amplification Detection and Diagnostics industry chain, the market status of Hospital and Clinics (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS)), Diagnostic Centers (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nucleic Acid Amplification Detection and Diagnostics.
Regionally, the report analyzes the Nucleic Acid Amplification Detection and Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nucleic Acid Amplification Detection and Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nucleic Acid Amplification Detection and Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nucleic Acid Amplification Detection and Diagnostics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nucleic Acid Amplification Detection and Diagnostics market.
Regional Analysis: The report involves examining the Nucleic Acid Amplification Detection and Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nucleic Acid Amplification Detection and Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nucleic Acid Amplification Detection and Diagnostics:
Company Analysis: Report covers individual Nucleic Acid Amplification Detection and Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nucleic Acid Amplification Detection and Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital and Clinics, Diagnostic Centers).
Technology Analysis: Report covers specific technologies relevant to Nucleic Acid Amplification Detection and Diagnostics. It assesses the current state, advancements, and potential future developments in Nucleic Acid Amplification Detection and Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nucleic Acid Amplification Detection and Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Nucleic Acid Amplification Detection and Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Isothermal Amplification Technology
Direct Nucleic Acid Detection
CRISPR-Cas9
Market segment by Application
Hospital and Clinics
Diagnostic Centers
Research Institutes
Others
Market segment by players, this report covers
BD
BioMerieux SA
BIO-RAD LABORATORIES INC.
THERMO FISHER SCIENTIFIC INC.
Illumina, Inc.
Danaher
QIAGEN
Abbott
Meridian Bioscience, Inc.
F. Hoffmann-La Roche Ltd.
PreAnalytiX
Eiken Chemical
Lucigen
OptiGene
NEB
Quidel Corporation
Promega
Hologic
Ustar
Grifols
Nugen
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nucleic Acid Amplification Detection and Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nucleic Acid Amplification Detection and Diagnostics, with revenue, gross margin and global market share of Nucleic Acid Amplification Detection and Diagnostics from 2019 to 2024.
Chapter 3, the Nucleic Acid Amplification Detection and Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Nucleic Acid Amplification Detection and Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nucleic Acid Amplification Detection and Diagnostics.
Chapter 13, to describe Nucleic Acid Amplification Detection and Diagnostics research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Nucleic Acid Amplification Detection and Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Nucleic Acid Amplification Detection and Diagnostics by Type
1.3.1 Overview: Global Nucleic Acid Amplification Detection and Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Nucleic Acid Amplification Detection and Diagnostics Consumption Value Market Share by Type in 2023
1.3.3 Polymerase Chain Reaction (PCR)
1.3.4 Next Generation Sequencing (NGS)
1.3.5 Isothermal Amplification Technology
1.3.6 Direct Nucleic Acid Detection
1.3.7 CRISPR-Cas9
1.4 Global Nucleic Acid Amplification Detection and Diagnostics Market by Application
1.4.1 Overview: Global Nucleic Acid Amplification Detection and Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital and Clinics
1.4.3 Diagnostic Centers
1.4.4 Research Institutes
1.4.5 Others
1.5 Global Nucleic Acid Amplification Detection and Diagnostics Market Size & Forecast
1.6 Global Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast by Region
1.6.1 Global Nucleic Acid Amplification Detection and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Nucleic Acid Amplification Detection and Diagnostics Market Size by Region, (2019-2030)
1.6.3 North America Nucleic Acid Amplification Detection and Diagnostics Market Size and Prospect (2019-2030)
1.6.4 Europe Nucleic Acid Amplification Detection and Diagnostics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Nucleic Acid Amplification Detection and Diagnostics Market Size and Prospect (2019-2030)
1.6.6 South America Nucleic Acid Amplification Detection and Diagnostics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Nucleic Acid Amplification Detection and Diagnostics Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.1.4 BD Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 BD Recent Developments and Future Plans
2.2 BioMerieux SA
2.2.1 BioMerieux SA Details
2.2.2 BioMerieux SA Major Business
2.2.3 BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.2.4 BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 BioMerieux SA Recent Developments and Future Plans
2.3 BIO-RAD LABORATORIES INC.
2.3.1 BIO-RAD LABORATORIES INC. Details
2.3.2 BIO-RAD LABORATORIES INC. Major Business
2.3.3 BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.3.4 BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 BIO-RAD LABORATORIES INC. Recent Developments and Future Plans
2.4 THERMO FISHER SCIENTIFIC INC.
2.4.1 THERMO FISHER SCIENTIFIC INC. Details
2.4.2 THERMO FISHER SCIENTIFIC INC. Major Business
2.4.3 THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.4.4 THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 THERMO FISHER SCIENTIFIC INC. Recent Developments and Future Plans
2.5 Illumina, Inc.
2.5.1 Illumina, Inc. Details
2.5.2 Illumina, Inc. Major Business
2.5.3 Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.5.4 Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Illumina, Inc. Recent Developments and Future Plans
2.6 Danaher
2.6.1 Danaher Details
2.6.2 Danaher Major Business
2.6.3 Danaher Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.6.4 Danaher Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Danaher Recent Developments and Future Plans
2.7 QIAGEN
2.7.1 QIAGEN Details
2.7.2 QIAGEN Major Business
2.7.3 QIAGEN Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.7.4 QIAGEN Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 QIAGEN Recent Developments and Future Plans
2.8 Abbott
2.8.1 Abbott Details
2.8.2 Abbott Major Business
2.8.3 Abbott Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.8.4 Abbott Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Abbott Recent Developments and Future Plans
2.9 Meridian Bioscience, Inc.
2.9.1 Meridian Bioscience, Inc. Details
2.9.2 Meridian Bioscience, Inc. Major Business
2.9.3 Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.9.4 Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Meridian Bioscience, Inc. Recent Developments and Future Plans
2.10 F. Hoffmann-La Roche Ltd.
2.10.1 F. Hoffmann-La Roche Ltd. Details
2.10.2 F. Hoffmann-La Roche Ltd. Major Business
2.10.3 F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.10.4 F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
2.11 PreAnalytiX
2.11.1 PreAnalytiX Details
2.11.2 PreAnalytiX Major Business
2.11.3 PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.11.4 PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 PreAnalytiX Recent Developments and Future Plans
2.12 Eiken Chemical
2.12.1 Eiken Chemical Details
2.12.2 Eiken Chemical Major Business
2.12.3 Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.12.4 Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Eiken Chemical Recent Developments and Future Plans
2.13 Lucigen
2.13.1 Lucigen Details
2.13.2 Lucigen Major Business
2.13.3 Lucigen Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.13.4 Lucigen Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Lucigen Recent Developments and Future Plans
2.14 OptiGene
2.14.1 OptiGene Details
2.14.2 OptiGene Major Business
2.14.3 OptiGene Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.14.4 OptiGene Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 OptiGene Recent Developments and Future Plans
2.15 NEB
2.15.1 NEB Details
2.15.2 NEB Major Business
2.15.3 NEB Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.15.4 NEB Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 NEB Recent Developments and Future Plans
2.16 Quidel Corporation
2.16.1 Quidel Corporation Details
2.16.2 Quidel Corporation Major Business
2.16.3 Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.16.4 Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Quidel Corporation Recent Developments and Future Plans
2.17 Promega
2.17.1 Promega Details
2.17.2 Promega Major Business
2.17.3 Promega Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.17.4 Promega Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Promega Recent Developments and Future Plans
2.18 Hologic
2.18.1 Hologic Details
2.18.2 Hologic Major Business
2.18.3 Hologic Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.18.4 Hologic Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Hologic Recent Developments and Future Plans
2.19 Ustar
2.19.1 Ustar Details
2.19.2 Ustar Major Business
2.19.3 Ustar Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.19.4 Ustar Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Ustar Recent Developments and Future Plans
2.20 Grifols
2.20.1 Grifols Details
2.20.2 Grifols Major Business
2.20.3 Grifols Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.20.4 Grifols Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Grifols Recent Developments and Future Plans
2.21 Nugen
2.21.1 Nugen Details
2.21.2 Nugen Major Business
2.21.3 Nugen Nucleic Acid Amplification Detection and Diagnostics Product and Solutions
2.21.4 Nugen Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Nugen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Nucleic Acid Amplification Detection and Diagnostics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Nucleic Acid Amplification Detection and Diagnostics by Company Revenue
3.2.2 Top 3 Nucleic Acid Amplification Detection and Diagnostics Players Market Share in 2023
3.2.3 Top 6 Nucleic Acid Amplification Detection and Diagnostics Players Market Share in 2023
3.3 Nucleic Acid Amplification Detection and Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Nucleic Acid Amplification Detection and Diagnostics Market: Region Footprint
3.3.2 Nucleic Acid Amplification Detection and Diagnostics Market: Company Product Type Footprint
3.3.3 Nucleic Acid Amplification Detection and Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Nucleic Acid Amplification Detection and Diagnostics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Nucleic Acid Amplification Detection and Diagnostics Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Nucleic Acid Amplification Detection and Diagnostics Consumption Value Market Share by Application (2019-2024)
5.2 Global Nucleic Acid Amplification Detection and Diagnostics Market Forecast by Application (2025-2030)
6 North America
6.1 North America Nucleic Acid Amplification Detection and Diagnostics Consumption Value by Type (2019-2030)
6.2 North America Nucleic Acid Amplification Detection and Diagnostics Consumption Value by Application (2019-2030)
6.3 North America Nucleic Acid Amplification Detection and Diagnostics Market Size by Country
6.3.1 North America Nucleic Acid Amplification Detection and Diagnostics Consumption Value by Country (2019-2030)
6.3.2 United States Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
6.3.3 Canada Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
6.3.4 Mexico Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Nucleic Acid Amplification Detection and Diagnostics Consumption Value by Type (2019-2030)
7.2 Europe Nucleic Acid Amplification Detection and Diagnostics Consumption Value by Application (2019-2030)
7.3 Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Country
7.3.1 Europe Nucleic Acid Amplification Detection and Diagnostics Consumption Value by Country (2019-2030)
7.3.2 Germany Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
7.3.3 France Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
7.3.5 Russia Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
7.3.6 Italy Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Amplification Detection and Diagnostics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Nucleic Acid Amplification Detection and Diagnostics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Nucleic Acid Amplification Detection and Diagnostics Market Size by Region
8.3.1 Asia-Pacific Nucleic Acid Amplification Detection and Diagnostics Consumption Value by Region (2019-2030)
8.3.2 China Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
8.3.3 Japan Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
8.3.4 South Korea Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
8.3.5 India Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
8.3.7 Australia Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
9 South America
9.1 South America Nucleic Acid Amplification Detection and Diagnostics Consumption Value by Type (2019-2030)
9.2 South America Nucleic Acid Amplification Detection and Diagnostics Consumption Value by Application (2019-2030)
9.3 South America Nucleic Acid Amplification Detection and Diagnostics Market Size by Country
9.3.1 South America Nucleic Acid Amplification Detection and Diagnostics Consumption Value by Country (2019-2030)
9.3.2 Brazil Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
9.3.3 Argentina Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Country
10.3.1 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Consumption Value by Country (2019-2030)
10.3.2 Turkey Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
10.3.4 UAE Nucleic Acid Amplification Detection and Diagnostics Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Nucleic Acid Amplification Detection and Diagnostics Market Drivers
11.2 Nucleic Acid Amplification Detection and Diagnostics Market Restraints
11.3 Nucleic Acid Amplification Detection and Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Nucleic Acid Amplification Detection and Diagnostics Industry Chain
12.2 Nucleic Acid Amplification Detection and Diagnostics Upstream Analysis
12.3 Nucleic Acid Amplification Detection and Diagnostics Midstream Analysis
12.4 Nucleic Acid Amplification Detection and Diagnostics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
BD
BioMerieux SA
BIO-RAD LABORATORIES INC.
THERMO FISHER SCIENTIFIC INC.
Illumina, Inc.
Danaher
QIAGEN
Abbott
Meridian Bioscience, Inc.
F. Hoffmann-La Roche Ltd.
PreAnalytiX
Eiken Chemical
Lucigen
OptiGene
NEB
Quidel Corporation
Promega
Hologic
Ustar
Grifols
Nugen
听
听
*If Applicable.
